A forum for researchers, students and applicants in the field of cyclodextrin technology
The mortality rate of novel coronaviral disease (COVID-19) patients undergoing dialysis is considerably higher than that of patients with normal
The press release was published on the U.S. Food and Drug Administration website: On Apr. 26, 2022, the U.S. Food
The aim of this report is to review the literature and shed light on the uncertainties surrounding the use of
The Hungarian Association of Innovation awarded CycloLab with this prestigious prize due to its meaningful and very profitable innovation concerning
Over the past two years, the ACTIV programme, run by the US National Institutes of Health (NIH), has included more
Nature News evaluated antiviral drugs developed for the treatment of Covid-19. Clinical-trial data showed that molnupiravir, developed by the pharmaceutical
— Approval Based on Phase 3 Data Showing Veklury Significantly Reduced Risk of Hospitalization By 87% Compared with Placebo —
Gilead has conducted an analysis of genetic information currently available for the Omicron variant and found no additional prevalent mutations
In a recently published study intermolecular interactions of remdesivir and various cyclodextrin derivatives were characterized by extensive NMR spectroscopy. The
Efcacious therapeutics for Ebola virus disease are in great demand. Ebola virus infections mediated by mucosal exposure, and aerosolization in
